Leuven -TiGenix is pleased to announce that ChondroCelect®, its cell based medicinal product for cartilage repair in the knee, will be available and reimbursed for hospital use in Belgium with effect from May 1st 2011.
ChondroCelect® available and reimbursed in Belgium